Pharmaceutical Technology

JULY 14, 2022

This analysis covers late April to May and is based on a list of CMOs impacted by regulatory decisions by the US Food and Drug Administration (FDA), European Medicines Agency (EMA), and reimbursement authorities like the UK’s National Institute of Health and Care Excellence (NICE). Covid-19 vaccines stay in the spotlight.

Vaccines 52

Vaccines Packaging FDA Pharmaceutical Companies 52

Pharma Marketing Network

MAY 11, 2023

Pharmaceutical companies have made major strides in developing new treatments for Alzheimer’s disease, offering hope for the millions of people affected by this debilitating condition. Food and Drug Administration (FDA) in June 2021. 2021, June 7). 2021, December 8). 2021, September 1).

FDA 52

FDA Pharmaceutical Companies Pharmaceutical Companies Vaccines 52

Pharma Marketing Network

MARCH 23, 2023

Pharmaceutical companies have made major strides in developing new treatments for Alzheimer’s disease, offering hope for the millions of people affected by this debilitating condition. Food and Drug Administration (FDA) in June 2021.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies FDA Vaccines 52

PharmaShots

APRIL 12, 2023

The company's mRNA platform comprises advances across three components, i.e., mRNA, delivery, and the manufacturing process. Moderna's 2022 revenue increased by 0.04% vs. 2021. Merck KGaA's 2022 revenue depicted an inclination of 6.56% vs. 2021. Novo's 2022 revenue increased by 0.18% vs. 2021.

Vaccines 64

Vaccines FDA Pharmaceutical Companies Pharmaceutical Companies 64

PharmaShots

MAY 23, 2023

Was ranked the highest among the list of companies developing Cell & Gene therapy, followed by Novartis with a revenue of $50.54B and Spark Therapeutics with a revenue of $49.27B PharmaShots brings an informative report on the Top 20 Cell and Gene Therapy Companies based on the total Revenue generated in the year 2022 Total Revenue: $0.5M

FDA 58

FDA Pharmaceutical Companies Pharmaceutical Companies Immunization 58

Pharmaceutical Technology

APRIL 12, 2023

In 2021, they accounted for 0.2% However, according to the US Food and Drug Administration (FDA), non-human primates are still the most scientifically relevant large model to test biologic drugs for safety. Globally, non-human primates make up a relatively small percentage of the animals used in research.

Vaccines 98

Vaccines FDA Pharmaceutical Companies Pharmaceutical Companies 98

Pharmaceutical Technology

DECEMBER 9, 2022

Pharmaceutical Technology Excellence Rankings – The Verdict. Solvias is a Swiss-based pharmaceutical company focused on contract research, development and manufacturing. The company is ranked in the M&A, PRODUCT LAUNCHES and RESEARCH AND DEVELOPMENT categories in the 2022 Pharmaceutical Technology Excellence Rankings.

Vaccines 52

Vaccines Compounding FDA Packaging 52

pharmaphorum

JANUARY 9, 2023

1 Kenya, for example, entered the pandemic with no human vaccines manufacturing facility and established the BioVax institute for local vaccine manufacture with a major plant investment starting in 2023. More remains to be addressed, and not just by conventional pharmaceutical companies. Pharma boxed in?

Vaccines 78

Vaccines Pharmaceutical Companies Pharmaceutical Companies Documentation 78

pharmaphorum

JUNE 29, 2022

COVID vaccines and treatments have created a substantial market over and above the existing Rx market- IQVIA estimates that the cumulative value of COVID vaccines could be between $185 and 295bn to 2026. The prescription medicine market has recovered from the wild swings of the early pandemic with renewed growth.

HIV Treatment and Prevention Agents 57

HIV Treatment and Prevention Agents Vaccines Pharmaceutical Companies Pharmaceutical Companies 57

Pharmaceutical Technology

MAY 15, 2023

110 innovations will shape the pharmaceutical industry According to GlobalData’s Technology Foresights, which plots the S-curve for the pharmaceutical industry using innovation intensity models built on over 756,000 patents, there are 110 innovation areas that will shape the future of the industry.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Vaccines FDA 52

pharmaphorum

APRIL 16, 2021

IQVIA’s Sarah Rickwood reviews the launch of innovative medicines in 2020 and outlines three key pillars of activity for companies to focus on and address in 2021. Even with the vaccine roll-out, further waves of COVID infection and lockdowns mean these vital drivers of launch performance remain impacted in 2021, and even beyond.

Pharmaceutical Companies 67

Pharmaceutical Companies Pharmaceutical Companies Documentation Vaccines 67

PharmaShots

FEBRUARY 21, 2023

Market Cap: $8.46M Founded Year: 2004 Total Employees: ~4 Headquarters: Texas, United States Stock Exchange: OTCMKTS QSam Biosciences is a clinical-stage biotech company focused on developing and commercializing targeted therapeutic radiopharmaceutical products for treating cancer and related diseases.

FDA 56

FDA Dosage Pharmaceutical Companies Pharmaceutical Companies 56

PharmaShots

MARCH 9, 2023

Designation: Chief Commercial Officer (CCO) and President Award & Nominations: She has her mention in Fortune’s “Top 50 Most Powerful Women” in 2020, 2021, and 2022 ranking 16th, 11th, and 13th respectively. Other Affiliations: She is a fellow of the Royal Society (May 2021) associated with Merck.

FDA 40

FDA Pharmaceutical Companies Pharmaceutical Companies Immunization 40

Pharmaceutical Technology

DECEMBER 27, 2022

The Covid-19 pandemic pushed most markets into free fall, leading to increased wariness for completing large mergers and acquisitions (M&As) in the pharmaceutical sector. In 2022, Russia’s war on Ukraine struck the supply chain, eventually slowing manufacturing and causing shortages for multiple pharmaceutical companies.

FDA 52

FDA Pharmaceutical Companies Pharmaceutical Companies Vaccines 52

Pharmaceutical Technology

MARCH 22, 2023

According to the GlobalData report Contract Injectable Packaging Trends in the Bio/Pharma Industry , more than half (55%) of FDA drug approvals in 2021 were accounted for by injectables. During the Covid-19 pandemic, large-scale vaccine production placed unprecedented demand on the parenteral packaging industry.

Packaging 52

Packaging Compounding Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

DECEMBER 22, 2022

In 2021 the company announced that 97% of its electricity usage had been obtained from renewable sources such as wind, solar, hydroelectric, and biomass, with this increasing further in 2022. The company has founded a non-commercial Global Health Unit to meet these goals.

FDA 52

FDA Insurance Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

MARCH 22, 2023

In the 1990s, generic pharmaceutical companies in the European Union (EU) offshored the manufacturing of active pharmaceutical ingredients (API) primarily to China. The European Commission plans to launch its revised EU pharmaceutical package in Q1 2023 to ease drug shortages,” she says.

Packaging 105

Packaging FDA Pharmaceutical Companies Pharmaceutical Companies 105

ISPE

MAY 9, 2023

Surrounded by universities and community colleges with life sciences programs, companies in RTP were able to access highly skilled graduates, increasing employment in the state. By the 1990s, pharmaceutical companies were looking to partner with contract research organizations (CROs) for drug development and clinical trials.

Vaccines 94

Vaccines Pharmaceutical Companies Pharmaceutical Companies Medical Schools 94

PharmaShots

APRIL 13, 2023

model is a holistic approach to incorporate the same strategy to life science and pharmaceutical companies. A globally fast-growing, and largest pharmaceutical company in the world was created through a merger between Pfizer and Pharmacia. Its top 8 products contributed more than $1B to the company’s net revenue.

Vaccines 40

Vaccines Pharmaceutical Companies Pharmaceutical Companies Labelling 40